urea has been researched along with Mastocytosis, Systemic in 1 studies
pseudourea: clinical use; structure
isourea : A carboximidic acid that is the imidic acid tautomer of urea, H2NC(=NH)OH, and its hydrocarbyl derivatives.
Mastocytosis, Systemic: A group of disorders caused by the abnormal proliferation of MAST CELLS in a variety of extracutaneous tissues including bone marrow, liver, spleen, lymph nodes, and gastrointestinal tract. Systemic mastocytosis is commonly seen in adults. These diseases are categorized on the basis of clinical features, pathologic findings, and prognosis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The majority of gastrointestinal stromal tumors (GIST) harbor constitutively activating mutations in KIT tyrosine kinase." | 1.62 | Ripretinib and MEK Inhibitors Synergize to Induce Apoptosis in Preclinical Models of GIST and Systemic Mastocytosis. ( Flynn, DL; García-Valverde, A; Gupta, A; Serrano, C; Singh, J; Smith, BD, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gupta, A | 1 |
| Singh, J | 1 |
| García-Valverde, A | 1 |
| Serrano, C | 1 |
| Flynn, DL | 1 |
| Smith, BD | 1 |
1 other study available for urea and Mastocytosis, Systemic
| Article | Year |
|---|---|
Ripretinib and MEK Inhibitors Synergize to Induce Apoptosis in Preclinical Models of GIST and Systemic Mastocytosis.
Topics: Animals; Apoptosis; Cell Line, Tumor; Disease Models, Animal; Dose-Response Relationship, Drug; Drug | 2021 |